MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
9.41
-0.53 (-5.33%)
Oct 16, 2026, 4:00 PM EDT - Market closed
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $48.02 million as of October 16, 2026. It is the 30,544th most valuable company in the world and the 4,661st biggest in the United States. Its market cap has decreased by 28.17% in one year.
Market Cap
48.02M
Enterprise Value
39.21M
1-Year Change
-28.17%
Global Rank
Country Rank
#4,661 United States
Category
ChartMarket Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $48.02M, a decrease of -87.57%. That is a compound annual growth rate of -34.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 48.02M | -8.25% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 50.92M |
| Caribou Biosciences | 50.38M |
| Alterity Therapeutics | 49.42M |
| iBio, Inc. | 49.28M |
| Adicet Bio | 49.19M |
| LeonaBio | 48.99M |
| Mereo BioPharma Group | 48.39M |
| Werewolf Therapeutics | 47.63M |